Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: ViperChick Secret Agent 006.9 who wrote (13105)	8/17/1998 9:39:00 PM
From: Jenna	Read Replies (3) \| Respond to of 120523

Some "uplift" for VVUS? ..Vivus Gets Approval For Impotence Device In Six Countries MOUNTAIN VIEW, Calif. -(Dow Jones)- Vivus Inc.'s Muse impotence product was approved in Canada, New Zealand and Hong Kong, and approved and launched in Singapore, Thailand and the Philippines. Vivus (VVUS) said the Canadian approval triggered a $2 million milestone payment from Johnson & Johnson's (JNJ) Janssen Pharmaceutica unit. Copyright (c) 1998 Dow Jones & Company, Inc. All Rights Reserved.